Brokers upgrade these 3 shares: Which ones should you buy?

Catapult Group International Ltd (ASX:CAT) continues to climb.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors typically react positively to broker upgrades, and why shouldn't they?

After all, a target price upgrade shows that an analyst following a particular company has found something that makes them think the company should be worth more.

That is what has happened with Catapult Group International Ltd (ASX: CAT), ResMed Inc. (CHESS) (ASX: RMD) and Senetas Corporation Limited (ASX: SEN) this morning, with all three earning broker upgrades. But does that automatically make them a buy?

Catapult Group

Bell Potter lifted its price target on Catapult Group by 18% to $3.85 today, while Morgans recently increased its own price target by 21% to $4.29. Coincidentally, the shares hit an all-time high of that amount today, which represented an 8.9% lift on yesterday's closing price.

Catapult Group recently announced a capital raising and two strategic acquisitions that should enhance its product offering to customers. Catapult Group is a great business and it seems there is still plenty of room for the company to continue growing, but investors do need to be mindful of how much they're paying for the shares. Investors who are committed to buying may want to start off with a smaller target allocation in case the shares do pull back from here.

ResMed Inc.

ResMed Inc. is a company that manufactures and distributes products for the treatment of sleep-related breathing disorders, including sleep apnea. The shares are currently trading for $8.76, up 2% on yesterday's closing price.

Credit Suisse upgraded its own price target this morning to $9.15 per share – a narrow 4.5% above today's price. ResMed is a quality business but, before investors buy, they should also take a look at rivals Somnomed Limited (ASX: SOM) and Fisher & Paykel Healthcare Corp Ltd (ASX: FPH).

I find SomnoMed particularly interesting. Operating in the same industry, it is a smaller company than ResMed Inc. but produces a cheaper and less invasive product. While its product is also capable of monitoring patient compliance with treatment prescriptions, SomnoMed is a company well worth checking out and may have greater upside potential than ResMed.

Senetas Corporation

After slipping to a 52-week low last week, Senetas shares have been on fire following an earnings update from the group. The shares have soared 49% since hitting that low and are trading 8.3% higher today alone at 13 cents. The earnings upgrade is also likely what led Bell Potter to raise its price target by 6.7% to 16 cents.

Indeed, the earnings guidance provided by the company is certainly better than what the market had expected, and the shares could be worth a closer look today as a result.

However, investors need to keep in mind that the company is still in the early stages of its development and could well experience setbacks in the coming months and years. This is by no means a risk-free bet.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »